GlassScriptPhysician profile
Charles Frederick Fraley
NPI 1184892135
$1,895.03
in general payments reported to CMS, 2019-2025
24 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $679 · 2020: $426 · 2021: $328 · 2022: $432 · 2023: $30.98.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $30.98.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $30.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $355.31 | 2020-2023 | |
| Daiichi Sankyo INC. | $213.59 | 2019-2021 | |
| Novo Nordisk INC | $209.92 | 2020-2022 | |
| Allergan, INC. | $184.36 | 2019-2020 | |
| Takeda Pharmaceuticals U.S.A., INC. | $151.68 | 2019 | |
| Glaxosmithkline, LLC. | $115.09 | 2021-2022 | |
| Antares Pharma, INC. | $102.53 | 2022-2023 | Tlando, Nocdurna, Xyosted |
| Pfizer INC. | $96.37 | 2019-2021 | |
| Merck Sharp & Dohme LLC | $50.92 | 2019-2022 | |
| Aytu Biopharma, INC. | $47.18 | 2019 | |
| Janssen Pharmaceuticals, INC | $40.77 | 2019 | |
| Abbott Laboratories | $39.93 | 2022 | |
| Amgen INC. | $39.25 | 2020 | |
| Astellas Pharma US INC | $39.24 | 2019 | |
| Lilly USA, LLC | $34.54 | 2020 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $26.49 | 2019-2020 | |
| Nevro Corp. | $26.23 | 2019 | |
| Eisai INC. | $24.66 | 2021 | |
| Hologic Sales and Service, LLC | $19.04 | 2021 | |
| Otsuka America Pharmaceutical, INC. | $18.78 | 2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $18.44 | 2019 | |
| Ibsa Pharma INC. | $14.45 | 2022 | |
| Biohaven Pharmaceuticals, INC. | $13.17 | 2021 | |
| Astrazeneca Pharmaceuticals LP | $13.09 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Charles Fraley listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.